AA 是一种罕见的胃肠道癌症，发病率低，每 10 万人中约有 1.3 人发病，且属于罕见病范畴，目前尚无 FDA 批准的特效疗法。标准治疗方案为细胞减灭术联合腹腔热灌注化疗（CRS + HIPEC），但并非所有患者都适合手术。传统观念认为 AA 对全身化疗反应不佳，不过近年来，靶向治疗、免疫治疗和腹腔内定向治疗展现出一定潜力。

A targeted therapy is one that has been developed to affect a specific target, such as an enzyme or receptor. Targeted therapies can either block or increase the function of their target in order ...

Oligometastatic Disease Market Forecast DelveInsight's Oligometastatic Disease Market report offers an in-depth understanding of the epidem ...